Risankizumab 00074-5016
Product NDC
00074-5016- Manufacturer
- Abbvie Inc.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- September 30, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Risankizumab | 600 mg/10mL |
Packaging Options(1)
4 TRAY in 1 CASE (0074-5016-99) / 90 VIAL in 1 TRAY / 1 VIAL, SINGLE-DOSE in 1 VIAL / 10 mL in 1 VIAL, SINGLE-DOSE